Ad is loading...
MENU

FBIO Fortress Biotech Forecast, Technical & Fundamental Analysis

a developer of novel immunotherapy biologic agents

Industry Biotechnology
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FBIO is expected to report earnings to fall 76.86% to -21 cents per share on March 27

Fortress Biotech FBIO Stock Earnings Reports
Q4'23
Est.
$-0.22
Q3'23
Beat
by $2.27
Q2'23
Beat
by $0.16
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.08
The last earnings report on November 14 showed earnings per share of -93 cents, beating the estimate of -321 cents. With 817.83K shares outstanding, the current market capitalization sits at 39.42M.
A.I. Advisor
published General Information

General Information

a developer of novel immunotherapy biologic agents

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1111 Kane Concourse
Phone
+1 781 652-4500
Employees
186
Web
https://www.fortressbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTRN3.540.05
+1.43%
Lantern Pharma
TTSH6.45-0.02
-0.31%
Tile Shop Holdings
LEN168.85-0.95
-0.56%
Lennar Corp
BNT56.87-0.92
-1.59%
Brookfield Wealth Solutions Ltd
SA14.22-0.35
-2.40%
Seabridge Gold

FBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-8.92%
NTLA - FBIO
41%
Loosely correlated
-7.61%
AXON - FBIO
38%
Loosely correlated
-0.86%
PGEN - FBIO
38%
Loosely correlated
-7.11%
EDIT - FBIO
38%
Loosely correlated
-3.97%
CKPT - FBIO
38%
Loosely correlated
-9.26%
More